|Bid||0.00 x 800|
|Ask||0.00 x 1000|
|Day's range||78.29 - 79.64|
|52-week range||56.31 - 83.45|
|Beta (5Y monthly)||0.86|
|PE ratio (TTM)||25.88|
|Earnings date||03 Aug 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||83.31|
Henry Schein's (HSIC) PPE sales from medical business are likely to have maintained momentum in Q2. Also, global recovery trends of its dental business are expected to reflect on Q2 results.
HSIC vs. COO: Which Stock Is the Better Value Option?
MELVILLE, N.Y., July 20, 2021--Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that it will release its second quarter 2021 financial results before the stock market opens on Tuesday, August 3, 2021, and will provide a live webcast of its earnings conference call on the same day beginning at 10:00 a.m. Eastern time. Speakers on the call will include Stanley M. Bergman, Chairman of the Board